AF
ABMD

Amalgamated Financial’s Abiomed Inc ABMD Stock Holding History

Amalgamated Financial’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$3.95M Buy
+11,916
New +$3.67M 0.03% 591

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Amalgamated Financial's ABMD Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Abiomed Inc (ABMD) in Q1 2022: 11,916 shares worth $3.95M. The stake represents 0.03% of the portfolio and ranks #591 among its holdings.

500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.

  • Amalgamated Financial held 11,916 shares of Abiomed Inc worth $3.95M as of Q1 2022.
  • Abiomed Inc was a new Amalgamated Financial position in Q1 2022.
  • Abiomed Inc made up 0.03% of Amalgamated Financial's portfolio in Q1 2022, its #591 holding.
  • 500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.